11 Thu.
Johnson & Johnson Settles Talc Lawsuits for $6.5 Billion 존슨앤드존슨, 활석 관련 소송 65억 달러 배상 합의
Johnson & Johnson has agreed to a $6.5 billion settlement to resolve almost all U.S. lawsuits alleging that its talc-based products caused ovarian cancer.
This decision comes after decades of legal battles that have affected the company's finances and reputation.
The settlement plan involves a third bankruptcy filing by one of its subsidiaries, LTL Management.
$6.5 billion settlement 65억달러의 합의
ovarian cancer 난소암
settlement plan 합의 계획
bankruptcy filing 파산 신청
subsidiaries 자회사
The agreement requires approval from the claimants, who will enter a three-month voting period to achieve a 75% approval rate necessary for the settlement to proceed.
This process allows claimants to vote on the bankruptcy settlement.
Johnson & Johnson asserts that this plan offers a more favorable outcome for the claimants than ongoing litigation would.
claimants 소송 청구인
enter a three-month voting period 3개월의 투표기간에 들어가다
vote on the bankruptcy settlement 파산 합의에 대해 투표하다
offers a more favorable outcome 더 유리한 결과를 제공한다
ongoing litigation 소송이 지속되는 것
Apart from the ovarian cancer lawsuits, Johnson & Johnson still faces legal challenges regarding a small number of mesothelioma cases.
The company has already resolved most of these cases and continues to address the remaining ones separately.
Moreover, Johnson & Johnson has also settled claims with over 40 states regarding misleading information about the safety of its talc.
faces legal challenges 법적 문제에 직면해있다
mesothelioma 중피종
has also settled claims with over 40 states 40개 이상의 주와 배상 요구 문제를 해결했다
#귀트영스크립트 #귀트영 #귀가트이는영어 #귀트영script #귀트영7월 #귀가트이는영어 7월